In the follow-up study, we will further clarify the application of Rh-endostatin, confirm the clinical value of Rh-endostatin through more basic research evidence, provide a reference basis for the further application of Rh-endostatin, and also provide a new direction for the treatment of cervical cancer and other malignant tumor diseases. The gene discussed is COL18A1; the disease is cervical cancer.